Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of hypertonic saline and dornase alfa in children with cystic fibrosis
RBR-9rzr3rCompleted
- Sponsor
- Renata Maba Gonçalves
- Start
- Feb 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial in cystic fibrosis (CF) comparing Dornase alfa group with Hypertonic saline group (2 arms). Started Feb 2014; status: completed.
02
Drugs
dornase alfahypertonic saline
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on RBR-9rzr3r.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9rzr3r.